Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $6.6600 (-21.28%) ($6.6600 - $6.6600) on Wed. Mar. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.2% (three month average) | RSI | 50 | Latest Price | $6.6600(-21.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.2% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) IGOV(23%) GLD(20%) ICLN(18%) BLOK(17%) SLV(17%) | Factors Impacting ANPC price | ANPC will decline at least -5.1% in a week (0% probabilities). UUP(-13%) TBT(-10%) XLP(-9%) XLF(-8%) XHB(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.1% (StdDev 10.2%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $6.68 | 5 Day Moving Average | $6.53(1.99%) | 10 Day Moving Average | $6.65(0.15%) | 20 Day Moving Average | $6.68(-0.3%) | To recent high | -21.3% | To recent low | 25.9% | Market Cap | $57m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |